Domestic price of Rituximab

Rituximab (Rituximab) is a drug used to treat blood cancers and inflammation, including follicular lymphoma and diffuse large B-cell non-Hodgkin lymphoma (two types of non-Hodgkin lymphoma) gold lymphoma), chronic lymphocytic leukemia (CLL), severe rheumatoid arthritis, granulomatosis with polyangiitis (GPA or Wegener's granulomatosis) and microscopic polyangiitis (MPA), moderate to severe pemphigus vulgaris. Depending on the condition used for treatment, rituximab may be used alone or with chemotherapy, methotrexate, or corticosteroids. Normally the immune system produces inflammation to protect the body from infection. But in some cases, a group of cells in the immune system, called B cells, can cause unnecessary inflammation and damage the body's healthy tissues.

Rituximab has been launched in China and has entered the scope of Class B medical insurance. The use of rituximab must be carried out by doctors and medical staff. It is a strictly controlled drug and its purchase and use may be restricted. SpecificationsThe price of each box of 500mg/500mL may be around RMB 8,000, which is relatively expensive. Rituximab has also been launched overseas. The price of the original Indian version of 500mg/500mL per box may be around RMB 3,000 (the price may fluctuate due to exchange rates) . There are also generic rituximab drugs produced by other pharmaceutical companies in India. The price of 500mg/500mL per box may be around 1,500 yuan (the price may fluctuate due to exchange rates). Its drug ingredients are basically the same as those of domestic and foreign original drugs.